Pancreatic Cancer Research

ReviewTumour Biol2013

Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9.

Journal
Tumour Biol
Published
17 August 2013
Citations
87
Type
Review

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

Pancreatic adenocarcinoma accounts for nearly 90-95% of exocrine malignant tumors of the pancreas. Traditionally, overexpressed proteins/epitopes such as CA 19-9, CA-50, CEA, and many others were being used as pancreatic cancer tumor markers. … Excerpt only: this text is the publisher’s. Read it in full at the source.